SCHEMBL8645516

SCHEMBL8645516

O=C(O)C(=Cc1cccc(C(F)(F)F)c1)c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TBXAS1 P24557 2/20 0.51
P4HB P07237 1/20 0.51
TBXA2R P21731 1/20 0.47
MAOB P27338 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NAMPT P43490 1/20 0.45
CSF1R P07333 2/20 0.45
BRAF P15056 1/20 0.45
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
AKR1C1 Q04828 1/20 0.44
VNN1 O95497 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CES2 O00748 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8645512 1.00 TSHR (0.54) TSHRMEN1KMT2ATBXAS1P4HB
SCHEMBL8650840 0.82 TSHR (0.49) TSHRMEN1KMT2ATBXAS1P4HB
SCHEMBL3966289 0.81 AKR1C3 (0.58) MEN1KMT2AP4HBMAOBAKR1C1
SCHEMBL3966293 0.81 AKR1C3 (0.58) MEN1KMT2AP4HBMAOBAKR1C1
SCHEMBL4576463 0.81 AKR1C3 (0.58) MEN1KMT2AP4HBMAOBAKR1C1
SCHEMBL8646379 0.81 AKR1C1 (0.68) MEN1KMT2ATBXAS1AKR1C1ALDH1A1
SCHEMBL8646375 0.81 AKR1C1 (0.68) MEN1KMT2ATBXAS1AKR1C1ALDH1A1
SCHEMBL8649420 0.81 AKR1C3 (0.56) MEN1KMT2AALOX15NPSR1AKR1C1
SCHEMBL8649414 0.81 AKR1C3 (0.56) MEN1KMT2AALOX15NPSR1AKR1C1
SCHEMBL8643115 0.78 ALDH1A1 (0.59) MEN1KMT2AAKR1C1ALDH1A1CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861831-A1 HETEROARYL-SUBSTITUTED ACRYLOYLGUANIDINE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1998-09-02 EP disclosed